Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

Jee Hyun Kong, Elliott F. Winton, MD, Leonard Heffner, MD, Manila Gaddh, MD, Brittany Hill, PA-C, MMSc, MSc, MPH, Martha Arellano, MD, Fuad El-Rassi, Audrey Kim, Anand Jillella, MD, Vamsi K Kota

Blood (2017) 130 (Supplement 1): 1607.

https://doi.org/10.1182/blood.V130.Suppl_1.1607.1607

Published: 2017

Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 2793.

https://doi.org/10.1182/blood.V128.22.2793.2793

Published: 2016

Journal Articles

A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit

Guillermo Garcia Manero, Ehab Atallah, MD, Samer K Khaled, MD, Martha Arellano, MD, Mrinal M Patnaik, MBBS, Olatoyosi Odenike, MD, Hamid Sayar, MD, Mohan Tummala, Prapti A. Patel, MD, Richard G. Ghalie, MD, Bruno C. Medeiros, MD

Blood (2016) 128 (22): 100.

https://doi.org/10.1182/blood.V128.22.100.100

Published: 2016

Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

Jee Hyun Kong, MD, Hanna Jean Khoury, MD, Elliott F. Winton, MD, Leonard T. Heffner, MD, Manila Gaddh, MD, Martha Arellano, MD, Fuad El-Rassi, MD, Audrey S Kim, RN, Anand Jillella, MD, Imre Bodó, MDPhD, Vamsi Kota, MD

Blood (2016) 128 (22): 3093.

https://doi.org/10.1182/blood.V128.22.3093.3093

Published: 2016

Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 1622.

https://doi.org/10.1182/blood.V128.22.1622.1622

Published: 2016

Journal Articles

Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)

H. Jean Khoury, Vamsi Kota, M.B;B.S, Martha Arellano, MD, Stephanie L Bauer, ANP, Anand P Jillella, MD, Amelia Langston, MD, Zaid Al-Kadhimi, MD, Zachariah DeFilipp, MD, Audrey S Kim, RN, Elliott F. Winton, MD, John F Dipersio, MD PhD

Blood (2015) 126 (23): 1938.

https://doi.org/10.1182/blood.V126.23.1938.1938

Published: 2015

Journal Articles

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

Uma Borate, MD, Amanda Redden Hathaway, MD, Deniz Peker, MD, Bradford E Jackson, PhD, Vamsi K Kota, MD, Bijal D Shah, Ling Zhang, MD, Anand Jillella, MD, Martha Arellano, MD, Leonard T. Heffner, MD, Harry P Erba, MD PhD

Blood (2015) 126 (23): 4869.

https://doi.org/10.1182/blood.V126.23.4869.4869

Published: 2015

Journal Articles

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

Simon B. Zeichner, D.O., Shannon Gleason, M.L.S., Ana G. Antun, MD, Amelia Langston, MD, Leonard T Heffner, Jr., MD, Vamsi K Kota, MD, Manila Gaddh, MD, Martha Arellano, MD

Blood (2015) 126 (23): 4955.

https://doi.org/10.1182/blood.V126.23.4955.4955

Published: 2015

Journal Articles

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

Sarah Wheeler, PharmD, Harika Puttagunta, MD, Minal Surati, PharmD, Elyse Panjic, PharmD, Arpita Shah, PharmD, Martha Arellano, MD, Anand Jillella, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 4924.

https://doi.org/10.1182/blood.V126.23.4924.4924

Published: 2015

Journal Articles

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Anand Jillella, MD, Martha Arellano, MD, Asad Bashey, MD PhD, Sarah I. Vidito, DO, Robert K. Stuart, MD, Caleb Leung, Kaitlin Sitchenko, Manila Gaddh, MD, Leonard T Heffner, Jr., MD, Ravindra B. Kolhe, MD PhD, Jacques Galipeau, MD, Amelia Langston, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 3779.

https://doi.org/10.1182/blood.V126.23.3779.3779

Published: 2015

Journal Articles

Poor Outcomes with Hyper CVAD Induction for T-Cell Lymphoblastic Leukemia/Lymphoma

Vamsi K Kota, MD, Amanda Redden Hathaway, MD, Bijal D. Shah, MD, Deniz Peker, MD, Ling Zhang, MD, David L. Jaye, MD, Martha Arellano, MD, H Jean Khoury, Anand P Jillella, MD, Elliott F. Winton, MD, Leonard T Heffner, Jr., MD, Uma Borate, MD

Blood (2015) 126 (23): 3762.

https://doi.org/10.1182/blood.V126.23.3762.3762

Published: 2015

Journal Articles

Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Single US Center Experience

H Jean Khoury, Leonard T Heffner, Jr., MD, Martha Arellano, MD, Anand P Jillella, MD, Vamsi K Kota, MD, Elliott F. Winton, MD

Blood (2015) 126 (23): 4045.

https://doi.org/10.1182/blood.V126.23.4045.4045

Published: 2015

Journal Articles

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Who Switch to Imatinib Following Optimal Response to Second Generation Tyrosine Kinase Inhibitors

Vamsi K Kota, MD, Elliott F. Winton, MD, Martha Arellano, MD, Anand Jillella, Morgan L. McLemore, MD, Fuad El Rassi, MD, H Jean Khoury

Blood (2015) 126 (23): 1592.

https://doi.org/10.1182/blood.V126.23.1592.1592

Published: 2015

Journal Articles

A Randomized Phase II Study Of Sapacitabine In MDS Refractory To Hypomethylating Agents

Guillermo Garcia-Manero, MD, Selina M Luger, MD, Stuart Goldberg, MD, Jessica K Altman, MD, Martha Arellano, MD, Meir Wetzler, MD, Karen Seiter, MD, Judy Chiao, MD, Hagop M Kantarjian, MD

Blood (2013) 122 (21): 2752.

https://doi.org/10.1182/blood.V122.21.2752.2752

Published: 2013

Journal Articles

Molecular Characterization By miRNA Expression Profiling in Acute Promyelocytic Leukemia (APL): deregulation Of Mirnas May Identify Patients At Risk Of Early Death

Vamsi Kota, M.B.B.S, Anand Jillella, MD, Amyn Rojiani, MD, Martha Arellano, MD, Ravindra B. Kolhe, MD, PhD

Blood (2013) 122 (21): 1361.

https://doi.org/10.1182/blood.V122.21.1361.1361

Published: 2013

Journal Articles

Cerebrospinal Fluid Flow Cytometry in Acute Lymphoblastic Leukemia/Lymphoma: Is It Beneficial?.

Fuad El Rassi, MD, Zahi Mitri, MD, Leonard T Heffner, M.D., Amelia Langston, MD, Edmund K. Waller, MD, PhD, Elliott F. Winton, MD, Morgan L. McLemore, MD, Leon Bernal, MD, Martha Arellano, MD, H. Jean Khoury, MD, FACP

Blood (2012) 120 (21): 2576.

https://doi.org/10.1182/blood.V120.21.2576.2576

Published: 2012

Journal Articles

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

Taro Hitosugi, PhD, Lu Zhou, PhD, Jun Fan, PhD, Martha Arellano, MD, Hanna J. Khoury, MD, Benjamin H. Lee, MD, PhD, Titus Boggon, PhD, Sumin Kang, PhD, Chuan He, Jing Chen, PhD

Blood (2012) 120 (21): 860.

https://doi.org/10.1182/blood.V120.21.860.860

Published: 2012

Journal Articles

Incidence and Geographic Distribution of Adult Acute Lymphoblastic Leukemia in the State of Georgia

Fuad El Rassi, MD, Martha Arellano, MD, Leonard T Heffner, MD, Edmund K. Waller, MD, PhD, Elliott F. Winton, MD, Kevin Ward, PhD, MPH, CTR, H. Jean Khoury, MD, FACP

Blood (2012) 120 (21): 4309.

https://doi.org/10.1182/blood.V120.21.4309.4309

Published: 2012

Journal Articles

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Rajni Sinha, MD, MRCP, Nassoma King, PA, Pareen J Shenoy, MBBS, MPH, Mary Jo Lechowicz, MD, Kevin Bumpers, MHA, Donald Hutcherson, Martha Arellano, MD, Amelia Langston, MD, Jonathan L. Kaufman, MD, Leonard T. Heffner, MD, Edmund K Waller, MD PhD, Christopher R Flowers, MD, Sagar Lonial, MD

Blood (2011) 118 (21): 1628.

https://doi.org/10.1182/blood.V118.21.1628.1628

Published: 2011

Journal Articles

Imatinib Mesylate and Hyper-CVAD (IM-HCVAD) for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Martha Arellano, MD, Disni Muringampurath-John, MD, Pareen J. Shenoy, MBBS, MPH, Elliott F. Winton, MD, Beverly Bryan, Amelia Langston, MD, Rajni Sinha, MD, MRCP, Morgan L. McLemore, MD, Leonard Heffner, MD, H. Jean Khoury, MD

Blood (2009) 114 (22): 4103.

https://doi.org/10.1182/blood.V114.22.4103.4103

Published: 2009

NARROW

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Ruxolitinib As Sparing Agent for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Poor Outcomes with Hyper CVAD Induction for T-Cell Lymphoblastic Leukemia/Lymphoma

Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Single US Center Experience

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Who Switch to Imatinib Following Optimal Response to Second Generation Tyrosine Kinase Inhibitors

A Randomized Phase II Study Of Sapacitabine In MDS Refractory To Hypomethylating Agents

Molecular Characterization By miRNA Expression Profiling in Acute Promyelocytic Leukemia (APL): deregulation Of Mirnas May Identify Patients At Risk Of Early Death

Cerebrospinal Fluid Flow Cytometry in Acute Lymphoblastic Leukemia/Lymphoma: Is It Beneficial?.

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

Incidence and Geographic Distribution of Adult Acute Lymphoblastic Leukemia in the State of Georgia

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Imatinib Mesylate and Hyper-CVAD (IM-HCVAD) for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only